Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 1/2

NCT06909136

A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With…

This is a Phase Ib/II clinical study to evaluate the safety , efficacy and pharmacokinetics of WJ01024 tablets combined with Ruxolitinib tablets in patients wit…

China33 participantsStarted 2025-07-28

Treatment: Ruxolitinib phosphate tablet（Jakavi,NOVARTIS,9104733)